EU Commission and Austria secure COVID-19 vaccines for the Western Balkans

21 April 2021
european_commission_large

The European Commission and Austria have announced the conclusion of agreements for the delivery of COVID-19 vaccines for the Western Balkans.

The 651,000 doses are funded through the 70 million-euro ($84 million) package adopted by the Commission in December 2020 and will be shared with the facilitation of Austria. The first delivery to all the partners in the region is due in May, with regular tranches to continue until August.

The President of the European Commission, Ursula von de Leyen, said: “It is crucial to speed up the vaccination campaigns everywhere. I am happy to announce that we have secured doses to help vaccinate health care workers and other vulnerable groups in the Western Balkans. The European Union stands by our partners in the region, who have been looking to us for support. I want to thank Austria for facilitating this transfer, showing its firm commitment and solidarity with the Western Balkans.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical